Clinical Research in Cardiology

, Volume 108, Issue 9, pp 974–989 | Cite as

Cardiac surgery 2018 reviewed

  • Torsten DoenstEmail author
  • Steffen Bargenda
  • Hristo Kirov
  • Alexandros Moschovas
  • Sophie Tkebuchava
  • Rauf Safarov
  • Mahmoud Diab
  • Gloria Faerber


For the year 2018, more than 22,000 published references can be found in PubMed when entering the search term “cardiac surgery”. As in the last 4 years, this review focusses on conventional cardiac surgery publications which provide important and interesting information especially relevant for non-surgical colleagues. Interventional techniques have been considered if they were published in the context of classic surgical techniques. We have again reviewed the fields of coronary revascularization and valve surgery and briefly touched on aortic surgery and surgery for terminal heart failure. For revascularization of complex coronary artery disease, bypass grafting was reconfirmed as gold standard and computer-tomographic angiography established equipoise for decision-making with classic angiography. For aortic valve treatment, some new longer-term outcomes from TAVI vs. SAVR trials confirmed equipoise of both treatments for high and medium risk. New information was provided for INR-management of mechanical aortic valves as well as long-term experiences for alternatives to mechanical valves (i.e., Ross and the relatively new Ozaki procedure). In the mitral and tricuspid field, prevalence data illustrate a significant amount of under-treatment for mitral and tricuspid valve regurgitation and evidence for life prolonging-effects of surgery. Finally, elongation of the ascending aorta was identified as new risk factor for aortic dissection and 2 years outcome of the newest generation of left ventricular assist devices demonstrate impressive improvements in outcome. While this article attempts to summarize the most pertinent publications, it does not expect to be complete and cannot be free of individual interpretation. As in recent years, it provides a condensed summary that is intended to give the reader “solid ground” for up-to-date decision-making in cardiac surgery and a stimulus for in-depth reading.


Coronary revascularization Aortic valve surgery Mitral valve surgery Tricuspid valve surgery Aortic surgery Left ventricular assist devices Heart transplantation 



We would like to thank Benjamin Gloy for expert technical assistance in the preparation of the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, Domanski MJ, Farkouh ME, Flather M, Fuster V, Hlatky MA, Holm NR, Hueb WA, Kamalesh M, Kim YH, Makikallio T, Mohr FW, Papageorgiou G, Park SJ, Rodriguez AE, Sabik JF 3rd, Stables RH, Stone GW, Serruys PW, Kappetein AP (2018) Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet 391(10124):939–948. CrossRefPubMedGoogle Scholar
  2. 2.
    Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, Domanski MJ, Farkouh ME, Flather M, Fuster V, Hlatky MA, Holm NR, Hueb WA, Kamalesh M, Kim YH, Makikallio T, Mohr FW, Papageorgiou G, Park SJ, Rodriguez AE, Sabik JF 3rd, Stables RH, Stone GW, Serruys PW, Kappetein AP (2018) Stroke rates following surgical versus percutaneous coronary revascularization. J Am Coll Cardiol 72(4):386–398. CrossRefPubMedGoogle Scholar
  3. 3.
    Zhao DF, Edelman JJ, Seco M, Bannon PG, Wilson MK, Byrom MJ, Thourani V, Lamy A, Taggart DP, Puskas JD, Vallely MP (2017) Coronary artery bypass grafting with and without manipulation of the ascending aorta: a network meta-analysis. J Am Coll Cardiol 69(8):924–936. CrossRefPubMedGoogle Scholar
  4. 4.
    Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO (2018) 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Farkouh ME, Domanski M, Dangas GD, Godoy LC, Mack MJ, Siami FS, Hamza TH, Shah B, Stefanini GG, Sidhu MS, Tanguay JF, Ramanathan K, Sharma SK, French J, Hueb W, Cohen DJ, Fuster V (2018) Long-term survival following multivessel revascularization in patients with diabetes (FREEDOM Follow-On Study). J Am Coll Cardiol. CrossRefPubMedGoogle Scholar
  6. 6.
    Gershlick AH, Kandzari DE, Banning A, Taggart DP, Morice MC, Lembo NJ, Brown WM 3rd, Banning AP, Merkely B, Horkay F, van Boven AJ, Boonstra PW, Dressler O, Sabik JF 3rd, Serruys PW, Kappetein AP, Stone GW (2018) Outcomes after left main percutaneous coronary intervention versus coronary artery bypass grafting according to lesion site: results from the EXCEL trial. JACC Cardiovasc Interv 11(13):1224–1233. CrossRefPubMedGoogle Scholar
  7. 7.
    Stone GW, Sabik JF, Serruys PW, Simonton CA, Genereux P, Puskas J, Kandzari DE, Morice MC, Lembo N, Brown WM 3rd, Taggart DP, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogats G, Mansour S, Noiseux N, Sabate M, Pomar J, Hickey M, Gershlick A, Buszman P, Bochenek A, Schampaert E, Page P, Dressler O, Kosmidou I, Mehran R, Pocock SJ, Kappetein AP (2016) Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med 375(23):2223–2235. CrossRefPubMedGoogle Scholar
  8. 8.
    Ruel M, Falk V, Farkouh ME, Freemantle N, Gaudino MF, Glineur D, Cameron DE, Taggart DP (2018) Myocardial revascularization trials. Circulation 138(25):2943–2951. CrossRefPubMedGoogle Scholar
  9. 9.
    Ram E, Goldenberg I, Kassif Y, Segev A, Lavee J, Einhorn-Cohen M, Raanani E (2018) Real-life characteristics and outcomes of patients who undergo percutaneous coronary intervention versus coronary artery bypass grafting for left main coronary artery disease: data from the prospective Multi-vessel Coronary Artery Disease (MULTICAD) Israeli Registry. Eur J Cardiothorac Surg 54(4):717–723. CrossRefPubMedGoogle Scholar
  10. 10.
    Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL (2016) Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med 374(16):1511–1520. CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Iribarne A, DiScipio AW, Leavitt BJ, Baribeau YR, McCullough JN, Weldner PW, Huang YL, Robich MP, Clough RA, Sardella GL, Olmstead EM, Malenka DJ (2018) Comparative effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in a real-world surgical treatment for ischemic heart failure trial population. J Thorac Cardiovasc Surg 156(4):1410–1421. CrossRefPubMedGoogle Scholar
  12. 12.
    Shah S, Benedetto U, Caputo M, Angelini GD, Vohra HA (2018) Comparison of the survival between coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with poor left ventricular function (ejection fraction < 30%): a propensity-matched analysis. Eur J Cardiothorac Surg. CrossRefPubMedGoogle Scholar
  13. 13.
    Cui K, Zhang D, Lyu S, Song X, Yuan F, Xu F, Zhang M (2018) Meta-analysis comparing percutaneous coronary revascularization using drug-eluting stent versus coronary artery bypass grafting in patients with left ventricular systolic dysfunction. Am J Cardiol. CrossRefPubMedGoogle Scholar
  14. 14.
    Collet C, Onuma Y, Andreini D, Sonck J, Pompilio G, Mushtaq S, La Meir M, Miyazaki Y, de Mey J, Gaemperli O, Ouda A, Maureira JP, Mandry D, Camenzind E, Macron L, Doenst T, Teichgraber U, Sigusch H, Asano T, Katagiri Y, Morel MA, Lindeboom W, Pontone G, Luscher TF, Bartorelli AL, Serruys PW (2018) Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease. Eur Heart J 39(41):3689–3698. CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Fournier S, Toth GG, De Bruyne B, Johnson NP, Ciccarelli G, Xaplanteris P, Milkas A, Strisciuglio T, Bartunek J, Vanderheyden M, Wyffels E, Casselman F, Van Praet F, Stockman B, Degrieck I, Barbato E (2018) Six-year follow-up of fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. Circ Cardiovasc Interv 11(6):e006368. CrossRefPubMedGoogle Scholar
  16. 16.
    Thuesen AL, Riber LP, Veien KT, Christiansen EH, Jensen SE, Modrau I, Andreasen JJ, Junker A, Mortensen PE, Jensen LO (2018) Fractional flow reserve versus angiographically-guided coronary artery bypass grafting. J Am Coll Cardiol 72(22):2732–2743. CrossRefPubMedGoogle Scholar
  17. 17.
    Doenst T, Haverich A, Serruys P, Bonow RO, Kappetein AP, Falk V, Velazquez EJ, Diegeler A, Sigusch H (2019) PCI and CABG for treating stable coronary artery disease: JACC review topic of the week. J Am Coll Cardiol 73(8):964–976. CrossRefPubMedGoogle Scholar
  18. 18.
    Newby DE, Adamson PD, Berry C, Boon NA, Dweck MR, Flather M, Forbes J, Hunter A, Lewis S, MacLean S, Mills NL, Norrie J, Roditi G, Shah ASV, Timmis AD, van Beek EJR, Williams MC (2018) Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med 379(10):924–933. CrossRefPubMedGoogle Scholar
  19. 19.
    Pinho-Gomes AC, Azevedo L, Ahn JM, Park SJ, Hamza TH, Farkouh ME, Serruys PW, Milojevic M, Kappetein AP, Stone GW, Lamy A, Fuster V, Taggart DP (2018) Compliance with guideline-directed medical therapy in contemporary coronary revascularization trials. J Am Coll Cardiol 71(6):591–602. CrossRefPubMedGoogle Scholar
  20. 20.
    Andersson B, She L, Tan RS, Jeemon P, Mokrzycki K, Siepe M, Romanov A, Favaloro LE, Djokovic LT, Raju PK, Betlejewski P, Racine N, Ostrzycki A, Nawarawong W, Das S, Rouleau JL, Sopko G, Lee KL, Velazquez EJ, Panza JA (2018) The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial. Eur Heart J 39(37):3464–3471. CrossRefPubMedGoogle Scholar
  21. 21.
    Cardoso R, Knijnik L, Whelton SP, Rivera M, Gluckman TJ, Metkus TS, Blumenthal RS, McEvoy JW (2018) Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: an updated meta-analysis. Int J Cardiol 269:80–88. CrossRefPubMedGoogle Scholar
  22. 22.
    Zhao Q, Zhu Y, Xu Z, Cheng Z, Mei J, Chen X, Wang X (2018) Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year after coronary artery bypass grafting: a randomized clinical trial. JAMA 319(16):1677–1686. CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Zenati MA, Bhatt DL, Bakaeen FG, Stock EM, Biswas K, Gaziano JM, Kelly RF, Tseng EE, Bitondo J, Quin JA, Almassi GH, Haime M, Hattler B, DeMatt E, Scrymgeour A, Huang GD (2018) Randomized trial of endoscopic or open vein-graft harvesting for coronary-artery bypass. N Engl J Med. CrossRefPubMedGoogle Scholar
  24. 24.
    Ueki C, Miyata H, Motomura N, Sakata R, Sakaguchi G, Akimoto T, Takamoto S (2018) Off-pump technique reduces surgical mortality after elective coronary artery bypass grafting in patients with preoperative renal failure. J Thorac Cardiovasc Surg 156(3):976–983. CrossRefPubMedGoogle Scholar
  25. 25.
    Chikwe J, Lee T, Itagaki S, Adams DH, Egorova NN (2018) Long-term outcomes after off-pump versus on-pump coronary artery bypass grafting by experienced surgeons. J Am Coll Cardiol 72(13):1478–1486. CrossRefPubMedGoogle Scholar
  26. 26.
    Doenst T, Essa Y, Jacoub K, Moschovas A, Gonzalez-Lopez D, Kirov H, Diab M, Bargenda S, Faerber G (2017) Cardiac surgery 2016 reviewed. Clin Res Cardiol 106(11):851–867. CrossRefPubMedGoogle Scholar
  27. 27.
    Doenst T, Kirov H, Moschovas A, Gonzalez-Lopez D, Safarov R, Diab M, Bargenda S, Faerber G (2018) Cardiac surgery 2017 reviewed. Clin Res Cardiol 107(12):1087–1102. CrossRefPubMedGoogle Scholar
  28. 28.
    Taggart D (2018) Randomized comparison of single versus bilateral internal thoracic artery grafts in 3102 CABG patients: major cardiovascular outcomes at 10 years of follow-up. In: Paper presented at the ESC, MunichGoogle Scholar
  29. 29.
    Mack M, Taggart D (2018) Coronary revascularization should be a subspecialty focus in cardiac surgery. J Thorac Cardiovasc Surg. CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Giambruno V, Jones P, Khaliel F, Chu MW, Teefy P, Sridhar K, Cucchietti C, Barnfield R, Kiaii B (2018) Hybrid coronary revascularization versus on-pump coronary artery bypass grafting. Ann Thorac Surg 105(5):1330–1335. CrossRefPubMedGoogle Scholar
  31. 31.
    Diab M, Farber G, Sponholz C, Tasar R, Lehmann T, Tkebuchava S, Franz M, Doenst T (2018) Coronary artery bypass grafting using bilateral internal thoracic arteries through a left-sided minithoracotomy: a single-center starting experience. Thorac Cardiovasc Surg. CrossRefPubMedGoogle Scholar
  32. 32.
    Windecker S, Neumann FJ, Juni P, Sousa-Uva M, Falk V (2019) Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of the task force of the 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 40(2):204–212. CrossRefPubMedGoogle Scholar
  33. 33.
    Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Munoz D, Rosenhek R, Sjogren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL (2017) 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38(36):2739–2791. CrossRefGoogle Scholar
  34. 34.
    Armoiry X, Obadia JF, Pascal L, Polazzi S, Duclos A (2018) Comparison of transcatheter versus surgical aortic valve implantation in high-risk patients: a nationwide study in France. J Thorac Cardiovasc Surg 156(3):1017–1025. CrossRefPubMedGoogle Scholar
  35. 35.
    Gleason TG, Reardon MJ, Popma JJ, Deeb GM, Yakubov SJ, Lee JS, Kleiman NS, Chetcuti S, Hermiller JB, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte JV, Mumtaz M, Oh JK, Huang J, Adams DH (2018) Self-expanding transcatheter aortic valve replacement or surgical valve replacement in high-risk patients: 5-year outcomes. J Am Coll Cardiol. CrossRefPubMedGoogle Scholar
  36. 36.
    Reardon MJ, Adams DH, Kleiman NS, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Lee JS, Hermiller JB Jr, Chetcuti S, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Qiao H, Popma JJ (2015) 2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol 66(2):113–121. CrossRefPubMedGoogle Scholar
  37. 37.
    Shah S, Alashi A, Pettersson GB, Rodriguez LL, Gillinov AM, Grimm RA, Navia J, Kapadia SR, Svensson LG, Griffin BP, Desai MY (2018) Characteristics and longer-term outcomes of paravalvular leak after aortic and mitral valve surgery. J Thorac Cardiovasc Surg. CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Doenst T, Richter M (2018) Paravalvular leaks in valve replacement: do we need to blow the whistle? J Thorac Cardiovasc Surg. CrossRefPubMedGoogle Scholar
  39. 39.
    Furukawa N, Kuss O, Emmel E, Scholtz S, Scholtz W, Fujita B, Ensminger S, Gummert JF, Borgermann J (2018) Minimally invasive versus transapical versus transfemoral aortic valve implantation: a one-to-one-to-one propensity score-matched analysis. J Thorac Cardiovasc Surg 156(5):1825–1834. CrossRefPubMedGoogle Scholar
  40. 40.
    Gozdek M, Raffa GM, Suwalski P, Kolodziejczak M, Anisimowicz L, Kubica J, Navarese EP, Kowalewski M (2018) Comparative performance of transcatheter aortic valve-in-valve implantation versus conventional surgical redo aortic valve replacement in patients with degenerated aortic valve bioprostheses: systematic review and meta-analysis. Eur J Cardiothorac Surg 53(3):495–504. CrossRefPubMedGoogle Scholar
  41. 41.
    Seiffert M, Treede H, Schofer J, Linke A, Woehrle J, Baumbach H, Mehilli J, Bapat V, Simonato M, Walther T, Kullmer M, Boekstegers P, Ensminger S, Kurz T, Eltchaninoff H, Rastan A, Werner N, de Weger A, Frerker C, Lauer B, Muller O, Whisenant B, Thukkani A, Weisz G, Dvir D (2018) Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve implantations in failed surgical aortic bioprostheses. EuroIntervention 14(4):e397–e404. CrossRefPubMedGoogle Scholar
  42. 42.
    Beckmann A, Meyer R, Lewandowski J, Frie M, Markewitz A, Harringer W (2018) German heart surgery report 2017: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 66(8):608–621. CrossRefPubMedGoogle Scholar
  43. 43.
    Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH (2000) Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 36(4):1152–1158CrossRefPubMedGoogle Scholar
  44. 44.
    Puskas J, Gerdisch M, Nichols D, Quinn R, Anderson C, Rhenman B, Fermin L, McGrath M, Kong B, Hughes C, Sethi G, Wait M, Martin T, Graeve A (2014) Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. J Thorac Cardiovasc Surg 147(4):1202–1210. (discussion 1210–1201) CrossRefPubMedGoogle Scholar
  45. 45.
    Puskas JD, Gerdisch M, Nichols D, Fermin L, Rhenman B, Kapoor D, Copeland J, Quinn R, Hughes GC, Azar H, McGrath M, Wait M, Kong B, Martin T, Douville EC, Meyer S, Ye J, Jamieson WRE, Landvater L, Hagberg R, Trotter T, Armitage J, Askew J, Accola K, Levy P, Duncan D, Yanagawa B, Ely J, Graeve A (2018) Anticoagulation and antiplatelet strategies after On-X mechanical aortic valve replacement. J Am Coll Cardiol 71(24):2717–2726. CrossRefPubMedGoogle Scholar
  46. 46.
    Buratto E, Shi WY, Wynne R, Poh CL, Larobina M, O’Keefe M, Goldblatt J, Tatoulis J, Skillington PD (2018) Improved survival after the Ross procedure compared with mechanical aortic valve replacement. J Am Coll Cardiol 71(12):1337–1344. CrossRefPubMedGoogle Scholar
  47. 47.
    Doenst T, Borger MA, Weisel RD, Yau TM, Maganti M, Rao V (2008) Relation between aortic cross-clamp time and mortality—not as straightforward as expected. Eur J Cardiothorac Surg 33(4):660–665. CrossRefPubMedGoogle Scholar
  48. 48.
    Ozaki S, Kawase I, Yamashita H, Uchida S, Takatoh M, Kiyohara N (2018) Midterm outcomes after aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium. J Thorac Cardiovasc Surg 155(6):2379–2387. CrossRefPubMedGoogle Scholar
  49. 49.
    Doenst T, Diab M, Sponholz C, Bauer M, Farber G (2017) The opportunities and limitations of minimally invasive cardiac surgery. Dtsch Arztebl Int 114(46):777–784. CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Sohn SH, Jang MJ, Hwang HY, Kim KH (2018) Rapid deployment or sutureless versus conventional bioprosthetic aortic valve replacement: a meta-analysis. J Thorac Cardiovasc Surg 155(6):2402–2412.e2405. CrossRefPubMedGoogle Scholar
  51. 51.
    Ensminger S, Fujita B, Bauer T, Mollmann H, Beckmann A, Bekeredjian R, Bleiziffer S, Landwehr S, Hamm CW, Mohr FW, Katus HA, Harringer W, Walther T, Frerker C (2018) Rapid deployment versus conventional bioprosthetic valve replacement for aortic stenosis. J Am Coll Cardiol 71(13):1417–1428. CrossRefPubMedGoogle Scholar
  52. 52.
    Nair SK, Sudarshan CD, Thorpe BS, Singh J, Pillay T, Catarino P, Valchanov K, Codispoti M, Dunning J, Abu-Omar Y, Moorjani N, Matthews C, Freeman CJ, Fox-Rushby JA, Sharples LD (2018) Mini-Stern Trial: a randomized trial comparing mini-sternotomy to full median sternotomy for aortic valve replacement. J Thorac Cardiovasc Surg. CrossRefPubMedGoogle Scholar
  53. 53.
    Merk DR, Lehmann S, Holzhey DM, Dohmen P, Candolfi P, Misfeld M, Mohr FW, Borger MA (2015) Minimal invasive aortic valve replacement surgery is associated with improved survival: a propensity-matched comparison. Eur J Cardiothorac Surg 47(1):11–17. (discussion 17) CrossRefPubMedGoogle Scholar
  54. 54.
    Dziadzko V, Clavel MA, Dziadzko M, Medina-Inojosa JR, Michelena H, Maalouf J, Nkomo V, Thapa P, Enriquez-Sarano M (2018) Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet 391(10124):960–969. CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Monteagudo Ruiz JM, Galderisi M, Buonauro A, Badano L, Aruta P, Swaans MJ, Sanchis L, Saraste A, Monaghan M, Theodoropoulos KC, Papitsas M, Liel-Cohen N, Kobal S, Bervar M, Berlot B, Filippatos G, Ikonomidis I, Katsanos S, Tanner FC, Cassani D, Faletra FF, Leo LA, Martinez A, Matabuena J, Grande-Trillo A, Alonso-Rodriguez D, Mesa D, Gonzalez-Alujas T, Sitges M, Carrasco-Chinchilla F, Li CH, Fernandez-Golfin C, Zamorano JL (2018) Overview of mitral regurgitation in Europe: results from the European Registry of mitral regurgitation (EuMiClip). Eur Heart J Cardiovasc Imaging 19(5):503–507. CrossRefPubMedGoogle Scholar
  56. 56.
    Grigioni F, Clavel MA, Vanoverschelde JL, Tribouilloy C, Pizarro R, Huebner M, Avierinos JF, Barbieri A, Suri R, Pasquet A, Rusinaru D, Gargiulo GD, Oberti P, Theron A, Bursi F, Michelena H, Lazam S, Szymanski C, Nkomo VT, Schumacher M, Bacchi-Reggiani L, Enriquez-Sarano M (2018) The MIDA Mortality Risk Score: development and external validation of a prognostic model for early and late death in degenerative mitral regurgitation. Eur Heart J 39(15):1281–1291. CrossRefPubMedGoogle Scholar
  57. 57.
    Topilsky Y, Maltais S, Medina Inojosa J, Oguz D, Michelena H, Maalouf J, Mahoney DW, Enriquez-Sarano M (2018) Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. CrossRefPubMedGoogle Scholar
  58. 58.
    Kelly BJ, Ho Luxford JM, Butler CG, Huang CC, Wilusz K, Ejiofor JI, Rawn JD, Fox JA, Shernan SK, Muehlschlegel JD (2018) Severity of tricuspid regurgitation is associated with long-term mortality. J Thorac Cardiovasc Surg 155(3):1032–1038. CrossRefPubMedGoogle Scholar
  59. 59.
    Farber G, Tkebuchava S, Dawson RS, Kirov H, Diab M, Schlattmann P, Doenst T (2018) Minimally invasive, isolated tricuspid valve redo surgery: a safety and outcome analysis. Thorac Cardiovasc Surg 66(7):564–571. CrossRefPubMedGoogle Scholar
  60. 60.
    Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, Lefevre T, Piot C, Rouleau F, Carrie D, Nejjari M, Ohlmann P, Leclercq F, Saint Etienne C, Teiger E, Leroux L, Karam N, Michel N, Gilard M, Donal E, Trochu JN, Cormier B, Armoiry X, Boutitie F, Maucort-Boulch D, Barnel C, Samson G, Guerin P, Vahanian A, Mewton N (2018) Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. CrossRefPubMedGoogle Scholar
  61. 61.
    Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ (2018) Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ (2017) Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 30(4):303–371. CrossRefPubMedGoogle Scholar
  63. 63.
    Grayburn PA, Carabello B, Hung J, Gillam LD, Liang D, Mack MJ, McCarthy PM, Miller DC, Trento A, Siegel RJ (2014) Defining “severe” secondary mitral regurgitation: emphasizing an integrated approach. J Am Coll Cardiol 64(25):2792–2801. CrossRefPubMedGoogle Scholar
  64. 64.
    Grayburn PA, Sannino A, Packer M (2019) Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT Trials. JACC Cardiovasc Imaging 12(2):353–362. CrossRefPubMedGoogle Scholar
  65. 65.
    Kruger T, Sandoval Boburg R, Lescan M, Oikonomou A, Schneider W, Vohringer L, Lausberg H, Bamberg F, Blumenstock G, Schlensak C (2018) Aortic elongation in aortic aneurysm and dissection: the Tubingen Aortic Pathoanatomy (TAIPAN) project. Eur J Cardiothorac Surg 54(1):26–33. CrossRefPubMedGoogle Scholar
  66. 66.
    Merkle J, Sabashnikov A, Deppe AC, Zeriouh M, Maier J, Weber C, Eghbalzadeh K, Schlachtenberger G, Shostak O, Djordjevic I, Kuhn E, Rahmanian PB, Madershahian N, Rustenbach C, Liakopoulos O, Choi YH, Kuhn-Regnier F, Wahlers T (2018) Impact of ascending aortic, hemiarch and arch repair on early and long-term outcomes in patients with Stanford A acute aortic dissection. Ther Adv Cardiovasc Dis 12(12):327–340. CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Mehra MR, Goldstein DJ, Uriel N, Cleveland JC Jr, Yuzefpolskaya M, Salerno C, Walsh MN, Milano CA, Patel CB, Ewald GA, Itoh A, Dean D, Krishnamoorthy A, Cotts WG, Tatooles AJ, Jorde UP, Bruckner BA, Estep JD, Jeevanandam V, Sayer G, Horstmanshof D, Long JW, Gulati S, Skipper ER, O’Connell JB, Heatley G, Sood P, Naka Y (2018) Two-year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med 378(15):1386–1395. CrossRefGoogle Scholar
  68. 68.
    Shah KB, Starling RC, Rogers JG, Horstmanshof DA, Long JW, Kasirajan V, Stehlik J, Chuang J, Farrar DJ, Estep JD (2018) Left ventricular assist devices versus medical management in ambulatory heart failure patients: an analysis of INTERMACS Profiles 4 and 5 to 7 from the ROADMAP study. J Heart Lung Transplant 37(6):706–714. CrossRefPubMedGoogle Scholar
  69. 69.
    Estep JD, Starling RC, Horstmanshof DA, Milano CA, Selzman CH, Shah KB, Loebe M, Moazami N, Long JW, Stehlik J, Kasirajan V, Haas DC, O’Connell JB, Boyle AJ, Farrar DJ, Rogers JG (2015) Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP Study. J Am Coll Cardiol 66(16):1747–1761. CrossRefPubMedGoogle Scholar
  70. 70.
    Daniel M, Chen C, Chung J, Goldberg L, Acker MA, Atluri P (2018) Interaction of donor and recipient age: do older heart transplant recipients require younger hearts? Ann Thorac Surg. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Cardiothoracic SurgeryFriedrich-Schiller-University of JenaJenaGermany

Personalised recommendations